Article

Ophthalmic market has growth in sight

Author(s):

Sheryl Stevenson

Philadelphia-In an uncertain economic climate, the ophthalmic market can take stock in knowing it is alive and well, according to Kenneth P. Taylor, an independent industry consultant.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
Edward Manche, MD
Related Content
Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease
November 18th 2024

Alkeus Pharmaceuticals receives FDA Rare Pediatric Disease and Fast Track designations for gildeuretinol as treatment for Stargardt disease

ROP: Treating and preventing blindness in preterm babies
October 18th 2021

ROP: Treating and preventing blindness in preterm babies

Study explores the true costs of treating pediatric cataracts
November 12th 2024

Study explores the true costs of treating pediatric cataracts

Managing a changing landscape of IRD pediatric cases
May 10th 2021

Managing a changing landscape of IRD pediatric cases

Cerebral visual impairment: A growing concern in pediatric vision loss
October 30th 2024

Cerebral visual impairment: A growing concern in pediatric vision loss

Factors affecting ROP development in the 8 weeks following birth
October 24th 2024

Factors affecting ROP development in the 8 weeks following birth

© 2024 MJH Life Sciences

All rights reserved.